What Leaders in the Field are Looking Forward to:

"This summit showcases the evolving therapeutic landscape, emphasizing the need for phase appropriate quality and regulatory flexibility to realize the true potential of mRNA medicine"

Martin Carvalho
Head - Quality, mRNA Centre of Excellence

"It is a great opportunity for scientists and other industry stakeholders to participate in the mRNA Process Development & Manufacturing Summit to discuss the current Industry challenges and find solutions or a path forward to advance affordable therapies into the market"

Srinivasulu Bandi
Director – BioProcess Development
Senda Biosciences

"The effective translation of mRNA science into products of relevance originates from a technical and scientific knowledge base. This summit brings such substance"

Petro Terblanche
Managing Director
Afrigen Biologics

"mRNA is a new modality with great potential for both vaccine and therapeutic indications. However, CMC and manufacturing technology are still in its infancy stage compared to traditional biologics. This conference offers great opportunity to share learnings, brainstorm on challenges and solutions, and network with fellow members within the field"

Jin Zhou
Executive Director - Process Development; mRNA & Protein Biologics
Ultragenyx Pharmaceutical

"I look forward to connecting with the community of mRNA drug development experts to discuss our challenges and opportunities in this nascent sector of the biotech market"

Emily English
Senior Director – Quality
Cartesian Therapeutics